(screenshot: REUTERS)
By REUTERS - December 7, 2016
Originally appeared here in The Jerusalem Post
Israeli biotech company Bonus Biogroup's lab-grown, semi-liquid bone graft was successfully injected into the jaws of 11 people to repair bone loss in an early stage clinical trial, it said on Monday.
The material, grown in a lab from each patient's own fat cells, was injected into and filled the voids of the problematic bones. Over a few months it hardened and merged with the existing bone to complete the jaw, it said. Read More